BCDA
Price
$2.35
Change
+$0.04 (+1.73%)
Updated
Jul 25 closing price
Capitalization
12.96M
INO
Price
$1.47
Change
-$0.04 (-2.65%)
Updated
Jul 25 closing price
Capitalization
74.91M
Interact to see
Advertisement

BCDA vs INO

Header iconBCDA vs INO Comparison
Open Charts BCDA vs INOBanner chart's image
BioCardia
Price$2.35
Change+$0.04 (+1.73%)
Volume$30.85K
Capitalization12.96M
Inovio Pharmaceuticals
Price$1.47
Change-$0.04 (-2.65%)
Volume$723.29K
Capitalization74.91M
BCDA vs INO Comparison Chart in %
Loading...
BCDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCDA vs. INO commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCDA is a StrongBuy and INO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (BCDA: $2.35 vs. INO: $1.47)
Brand notoriety: BCDA: Not notable vs. INO: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCDA: 20% vs. INO: 42%
Market capitalization -- BCDA: $12.96M vs. INO: $74.91M
BCDA [@Biotechnology] is valued at $12.96M. INO’s [@Biotechnology] market capitalization is $74.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCDA’s FA Score shows that 0 FA rating(s) are green whileINO’s FA Score has 0 green FA rating(s).

  • BCDA’s FA Score: 0 green, 5 red.
  • INO’s FA Score: 0 green, 5 red.
According to our system of comparison, both BCDA and INO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCDA’s TA Score shows that 6 TA indicator(s) are bullish while INO’s TA Score has 4 bullish TA indicator(s).

  • BCDA’s TA Score: 6 bullish, 3 bearish.
  • INO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BCDA is a better buy in the short-term than INO.

Price Growth

BCDA (@Biotechnology) experienced а +5.38% price change this week, while INO (@Biotechnology) price change was +5.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

BCDA is expected to report earnings on May 14, 2025.

INO is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INO($74.9M) has a higher market cap than BCDA($13M). BCDA YTD gains are higher at: 7.798 vs. INO (-17.416). BCDA has higher annual earnings (EBITDA): -8.39M vs. INO (-93.37M). INO has more cash in the bank: 68.4M vs. BCDA (949K). BCDA has less debt than INO: BCDA (850K) vs INO (11.3M). INO has higher revenues than BCDA: INO (283K) vs BCDA (3K).
BCDAINOBCDA / INO
Capitalization13M74.9M17%
EBITDA-8.39M-93.37M9%
Gain YTD7.798-17.416-45%
P/E RatioN/AN/A-
Revenue3K283K1%
Total Cash949K68.4M1%
Total Debt850K11.3M8%
FUNDAMENTALS RATINGS
BCDA vs INO: Fundamental Ratings
BCDA
INO
OUTLOOK RATING
1..100
845
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
51
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
5293
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INO's Valuation (51) in the Medical Specialties industry is somewhat better than the same rating for BCDA (90) in the null industry. This means that INO’s stock grew somewhat faster than BCDA’s over the last 12 months.

INO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as BCDA (100) in the null industry. This means that INO’s stock grew similarly to BCDA’s over the last 12 months.

INO's SMR Rating (98) in the Medical Specialties industry is in the same range as BCDA (100) in the null industry. This means that INO’s stock grew similarly to BCDA’s over the last 12 months.

BCDA's Price Growth Rating (52) in the null industry is somewhat better than the same rating for INO (93) in the Medical Specialties industry. This means that BCDA’s stock grew somewhat faster than INO’s over the last 12 months.

BCDA's P/E Growth Rating (100) in the null industry is in the same range as INO (100) in the Medical Specialties industry. This means that BCDA’s stock grew similarly to INO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCDAINO
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 17 days ago
79%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
BCDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MGRC124.508.54
+7.36%
McGrath RentCorp
IOT38.990.87
+2.28%
Samsara
ZKIN2.41N/A
N/A
ZK International Group Co Ltd
MNSB21.16-0.14
-0.66%
MainStreet Bancshares
VTS24.28-0.23
-0.94%
Vitesse Energy

BCDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCDA has been closely correlated with SMMT. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if BCDA jumps, then SMMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCDA
1D Price
Change %
BCDA100%
+1.73%
SMMT - BCDA
68%
Closely correlated
+3.99%
XRTX - BCDA
41%
Loosely correlated
-2.91%
BTAI - BCDA
30%
Poorly correlated
+4.62%
MDGL - BCDA
29%
Poorly correlated
-0.26%
INO - BCDA
28%
Poorly correlated
-2.65%
More